Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ARGAN INCAGX · Entity 3828 | Director | June 15, 2026 | June 16, 2026 |
| Forbright, Inc.FRBT · Entity 5025 | Director | July 16, 2026 | July 17, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ARGAN INC
Report date June 15, 2026 · Filed June 16, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 23,144 |
Reported balance
After 2026-06-15 transaction · row 1
1 source rowRow 1 · 2026-06-15 · Sale · Disposed 2,596 · Balance 23,144 F1: On June 15, 2026, the Reporting Person sold 2,596 shares of the Issuer's common stock on the open market at a price of $666.31 per share. |
Filing footnotes · ownership attribution and instrument terms
F1: On June 15, 2026, the Reporting Person sold 2,596 shares of the Issuer's common stock on the open market at a price of $666.31 per share.
Forbright, Inc.
Report date July 16, 2026 · Filed July 17, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 20,241 |
Reported balance
After 2026-07-16 transaction · row 1
1 source rowRow 1 · 2026-07-16 · Grant · Acquired 220 · Balance 20,241 F1: Represents fully vested deferred restricted stock units ("DRSUs") granted in lieu of the Reporting Person's quarterly cash retainer fee, which will settle in shares following the termination of the Reporting Person's service as a member of the Issuer's board of directors. Each DRSU represents a contingent right to receive one share of Class A common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents fully vested deferred restricted stock units ("DRSUs") granted in lieu of the Reporting Person's quarterly cash retainer fee, which will settle in shares following the termination of the Reporting Person's service as a member of the Issuer's board of directors. Each DRSU represents a contingent right to receive one share of Class A common stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 05, 2023 Filed Oct 12, 2023 22:04 UTC | ARGAN INC AGX · Entity 3828 | PurchaseCommon Stock | 7,000 | $26.88 | $188,160.00 |
DisclosureSEC source: 0001415889-23-014183 · form4-10122023_101044.xml · nonDerivative · entry 1 Flanders Cynthia · CIK 0001463638 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,000 F1 · shares: On October 5, 2023, the Reporting Person exercised the remaining portion of her stock option received on December 17, 2013 to purchase 7,000 shares of the Issuer's Common Stock at a price of $26.88 per share; then sold the shares on the open market at a price of $46.00 per share. Read SEC document |
| December 16, 2022 Filed Dec 20, 2022 21:15 UTC | ARGAN INC AGX · Entity 3828 | GrantTime-Based Restricted Stock Units · Derivative | 1,750 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-012845 · form4-12202022_041201.xml · derivative · entry 2 Flanders Cynthia · CIK 0001463638 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,500 Underlying: Common Stock · 1,750 shares Expires 2025-12-16 F4 · shares: On December 16, 2022, the Reporting Person was granted Time-Based Restricted Stock Units (the "TBRSUs") covering 1,750 shares of common stock. The TBRSUs will vest in their entirety on the third anniversary of the grant date on 12/16/2025. F5 · balance_after: As of the date of this filing, the total number of TBRSUs owned by the the Reporting Person includes (a) 1,750 shares TBRSUs granted on December 14, 2021 and (b) 1,750 shares of TBRSUs granted on December 16, 2022. All are to vest in their entirety on the third anniversary of their respective grant date. Read SEC document |
| December 16, 2022 Filed Dec 20, 2022 21:15 UTC | ARGAN INC AGX · Entity 3828 | GrantOption to Purchase Common Stock · Derivative | 5,000 | $0.00 Strike: $35.72 | $0.00 |
DisclosureSEC source: 0001415889-22-012845 · form4-12202022_041201.xml · derivative · entry 1 Flanders Cynthia · CIK 0001463638 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,000 Underlying: Common Stock · 5,000 shares Expires 2032-12-16 F1 · shares: On December 16, 2022, the Reporting Person received 10-year options to purchase 5,000 shares of the Issuer's common stock with an exercise price of $35.72 per share. The options will vest ratably over three years on each anniversary of the grant date starting from 12/16/2023. F2 · balance_after: As of the date of this filing, the Reporting Person owns options to purchase (a) 7,000 shares of common stock at a price of $26.88 per share with initial Date Exercisable of 12/17/2014 and Expiration Date of 12/17/2023; (b) 10,000 shares of common stock at a price of $31.82 per share with initial Date Exercisable of 12/11/2015 and Expiration Date of 12/11/2024; (c) 10,000 shares of common stock at a price of $30.44 per share with initial Date Exercisable of 1/7/2017 and Expiration Date of 1/7/2026; d) 10,000 shares of common stock at a price of $71.75 per share with initial Date Exercisable of 1/5/2018 and Expiration Date of 1/5/2027; (e) 10,000 shares of common stock at a price of $46.35 per share with initial Date Exercisable of 1/11/2019 and Expiration Date of 1/11/2028; (f) 10,000 shares of common stock at a price of $41.19 per share with initial Date Exercisable of 12/12/2019 and Expiration Date of 12/12/2028; F3 · balance_after: (g) 10,000 shares of common stock at a price of $40.15 per share with initial Date Exercisable of 12/23/2020 and Expiration Date of 12/23/2029; (h) 10,000 shares of common stock at a price of $45.75 per share with initial Date Exercisable of 12/14/2021 and Expiration Date of 12/14/2030; (i) 5,000 shares of common stock at a price of $37.13 per share with initial Date Exercisable of 12/14/2022 and Expiration Date of 12/14/2031; and (j) 5,000 shares of common stock at a price of 35.72 per share with initial Date Exercisable of 12/16/2023 and Expiration Date of 12/16/2032. All stock options are subject to the aforementioned three-year ratable vesting schedule except those awarded prior to January 2018 which vested fully on the first anniversary of the date of award. Read SEC document |
| December 14, 2021 Filed Dec 16, 2021 21:15 UTC | ARGAN INC AGX · Entity 3828 | GrantTime-Based Restricted Stock Units · Derivative | 1,750 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-21-006024 · form4-12162021_041201.xml · derivative · entry 3 Flanders Cynthia · CIK 0001463638 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,750 Underlying: Common Stock · 1,750 shares Expires 2024-12-14 F5 · shares: On December 14, 2021, the Reporting Person was granted Time-Based Restricted Stock Units (the "TBRSUs") covering 1,750 shares of common stock. The TBRSUs will vest in their entirety on the third anniversary of the grant date on 12/14/2024. Read SEC document |
| December 14, 2021 Filed Dec 16, 2021 21:15 UTC | ARGAN INC AGX · Entity 3828 | GrantOption to Purchase Common Stock · Derivative | 5,000 | $0.00 Strike: $37.13 | $0.00 |
DisclosureSEC source: 0001415889-21-006024 · form4-12162021_041201.xml · derivative · entry 2 Flanders Cynthia · CIK 0001463638 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,000 Underlying: Common Stock · 5,000 shares Expires 2031-12-14 F1 · shares: On December 14, 2021, the Reporting Person received 10-year options to purchase 5,000 shares of the Issuer's common stock with an exercise price of $37.13 per share. The options will vest ratably over three years on each anniversary of the grant date starting from 12/14/2022. F2 · balance_after: As of the date of this filing, the Reporting Person owns options to purchase (a) 7,000 shares of common stock at a price of $26.88 per share with initial Date Exercisable of 12/17/2014 and Expiration Date of 12/17/2023; (b) 10,000 shares of common stock at a price of $31.82 with initial Date Exercisable of 12/11/2015 and Expiration Date of 12/11/2024; (c) 10,000 shares of common stock at a price of $30.44 per share with initial Date Exercisable of 1/7/2017 and Expiration Date of 1/7/2026; F3 · balance_after: (d) 10,000 shares of common stock at a price of $71.75 per share with initial Date Exercisable of 1/5/2018 and Expiration Date of 1/5/2027; (e) 10,000 shares of common stock at a price of $46.35 per share with initial Date Exercisable of 1/11/2019 and Expiration Date of 1/11/2028; (f) 10,000 shares of common stock at a price of $41.19 per share with initial Date Exercisable of 12/12/2019 and Expiration Date of 12/12/2028; (g) 10,000 shares of common stock at a price of $40.15 per share with initial Date Exercisable of 12/23/2020 and Expiration Date of 12/23/2029; F4 · balance_after: (h) 10,000 shares of common stock at a price of $45.75 per share with initial Date Exercisable of 12/14/2021 and Expiration Date of 12/14/2030; and (i) 5,000 shares of common stock at a price of $37.13 per share with initial Date Exercisable of 12/14/2022 and Expiration Date of 12/14/2031. All stock options are subject to the aforementioned three-year ratable vesting schedule except those awarded prior to January 2018 which vested fully on the first anniversary of the date of award. Read SEC document |
| December 14, 2020 Filed Dec 16, 2020 21:18 UTC | ARGAN INC AGX · Entity 3828 | GrantStock Option to Purchase · Derivative | 10,000 | $0.00 Strike: $45.75 | $0.00 |
DisclosureSEC source: 0001104659-20-136300 · tm2038593d4_4seq1.xml · derivative · entry 2 Flanders Cynthia · CIK 0001463638 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,000 Underlying: Common Stock · 10,000 shares Expires 2030-12-14 F1 · shares: On December 14, 2020, the Reporting Person received 10-year options to purchase 10,000 shares of the Issuer's common stock with an exercise price of $45.75 per share. The options will vest ratably over three years on each anniversary of the grant date starting from 12/14/2021. F2 · balance_after: As of the date of this filing, the Reporting Person owns options to purchase (a) 7,000 shares of common stock at a price of $26.88 per share with initial Date Exercisable of 12/17/2014 and Expiration Date of 12/17/2023; (b) 10,000 shares of common stock at a price of $31.82 with initial Date Exercisable of 12/11/2015 and Expiration Date of 12/11/2024; (c) 10,000 shares of common stock at a price of $30.44 per share with initial Date Exercisable of 1/7/2017 and Expiration Date of 1/7/2026; (d) 10,000 shares of common stock at a price of $71.75 per share with initial Date Exercisable of 1/5/2018 and Expiration Date of 1/5/2027; (e) 10,000 shares of common stock at a price of $46.35 per share with initial Date Exercisable of 1/11/2019 and Expiration Date of 1/11/2028; F3 · balance_after: (f) 10,000 shares of common stock at a price of $41.19 per share with initial Date Exercisable of 12/12/2019 and Expiration Date of 12/12/2028; (g) 10,000 shares of common stock at a price of $40.15 per share with initial Date Exercisable of 12/23/2020 and Expiration Date of 12/23/2029; and (h) 10,000 shares of common stock at a price of $45.75 per share with initial Date Exercisable of 12/14/2021 and Expiration Date of 12/14/2030, all of which are subject to the aforementioned three-year ratably vesting schedule. Read SEC document |
| December 23, 2019 Filed Dec 26, 2019 16:11 UTC | ARGAN INC AGX · Entity 3828 | GrantStock Option to Purchase Common Stock · Derivative | 10,000 | $0.00 Strike: $40.15 | $0.00 |
DisclosureSEC source: 0001104659-19-075970 · a4.xml · derivative · entry 2 Flanders Cynthia · CIK 0001463638 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,000 Underlying: Common Stock · 10,000 shares Expires 2029-12-23 F1 · shares: On December 23, 2019 (the "Grant Date"), the Reporting Person received 10-year options, vesting ratably over three years on each anniversary date from the Grant Date, to purchase 10,000 shares of the Issuer's common stock with an exercise price of $40.15 per share. F2 · balance_after: As of the date of this filing, the total number of options owned by the Reporting Person includes (a) options to acquire 7,000 shares of common stock at a price of $26.88 per share with Date Exercisable of 12/17/2014 and Expiration Date of 12/17/2023; (b) options to acquire 10,000 shares of common stock at a price of $31.82 with Date Exercisable of 12/11/2015 and Expiration Date of 12/11/2024; (c) options to acquire 10,000 shares of common stock at a price of $30.44 per share with Date Exercisable of 1/7/2017 and Expiration Date of 1/7/2026; (d) options to acquire 10,000 shares of common stock at a price of $71.75 per share with Date Exercisable of 1/5/2018 and Expiration Date of 1/5/2027; (e) options to acquire 10,000 shares of common stock at a price of $46.35 per share with initial Date Exercisable of 1/11/2019 and Expiration Date of 1/11/2028; F3 · balance_after: (f) options to acquire 10,000 shares of common stock at a price of $41.19 per share with initial Date Exercisable beginning on 12/12/2019 and Expiration Date of 12/12/2028; and (g) options to acquire 10,000 shares of common stock at a price of $40.15 per share with initial Date Exercisable of 12/23/2020 and Expiration Date of 12/23/2029. Read SEC document |
| December 12, 2018 Filed Dec 14, 2018 00:26 UTC | ARGAN INC AGX · Entity 3828 | GrantStock Option to purchase Common Stock · Derivative | 10,000 | $0.00 Strike: $41.19 | $0.00 |
DisclosureSEC source: 0001104659-18-072877 · a4.xml · derivative · entry 2 Flanders Cynthia · CIK 0001463638 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,000 Underlying: Common Stock · 10,000 shares Expires 2028-12-12 F1 · shares: On December 12, 2018 (the "Grant Date"), the Reporting Person received 10-year options, vesting ratably over three years on each anniversary date from the Grant Date, to purchase 10,000 shares of the Issuer's common stock with an exercise price of $41.19 per share. F2 · balance_after: As of the date of this filing, the total number of options owned by the Reporting Person includes (a) options to acquire 7,000 shares of common stock at a price of $26.88 per share with Date Exercisable of 12/17/2014 and Expiration Date of 12/17/2023; (b) options to acquire 10,000 shares of common stock at a price of $31.82 with Date Exercisable of 12/11/2015 and Expiration Date of 12/11/2024; (c) options to acquire 10,000 shares of common stock at a price of $30.44 per share with Date Exercisable of 1/7/2017 and Expiration Date of 1/7/2026; F3 · balance_after: (d) options to acquire 10,000 shares of common stock at a price of $71.75 per share with Date Exercisable of 1/5/2018 and Expiration Date of 1/5/2027; (e) options to acquire 10,000 shares of common stock at a price of $46.35 per share with Date Exercisable of 1/11/2019 and Expiration Date of 1/11/2028; and (f) options to acquire 10,000 shares of common stock at a price of $41.19 per share with initial Date Exercisable beginning on 12/12/2019 and Expiration Date of 12/12/2028. Read SEC document |
| January 11, 2018 Filed Jan 12, 2018 21:40 UTC | ARGAN INC AGX · Entity 3828 | GrantStock Option to purchase Common Stock · Derivative | 10,000 | $0.00 Strike: $46.35 | $0.00 |
DisclosureSEC source: 0001104659-18-002083 · a4.xml · derivative · entry 2 Flanders Cynthia · CIK 0001463638 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,000 Underlying: Common Stock · 10,000 shares Expires 2028-01-11 F1 · shares: On January 11, 2018 (the "Grant Date"), the Reporting Person received 10-year options, vesting ratably over three years on each anniversary date from the Grant Date, to purchase 10,000 shares of the Issuer's common stock with an exercise price of $46.35 per share. F2 · balance_after: As of the date of this filing, the total number of options owned by the Reporting Person includes (a) options to acquire 7,000 shares of common stock at a price of $26.88 per share with Date Exercisable of 12/17/2014 and Expiration Date of 12/17/2023; (b) options to acquire 10,000 shares of common stock at a price of $31.82 with Date Exercisable of 12/11/2015 and Expiration Date of 12/11/2024; (c) options to acquire 10,000 shares of common stock at a price of $30.44 per share with Date Exercisable of 1/7/2017 and Expiration Date of 1/7/2026; (d) options to acquire 10,000 shares of common stock at a price of $71.75 per share with Date Exercisable of 1/5/2018 and Expiration Date of 1/5/2027; and (e) options to acquire 10,000 shares of common stock at a price of $46.35 per share with Date Exercisable of 1/11/2019 and Expiration Date of 1/11/2028. Read SEC document |
| December 27, 2017 Filed Dec 28, 2017 21:21 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionStock Option to purchase Common Stock · Derivative | 3,000 | $0.00 Strike: $26.88 | $0.00 |
DisclosureSEC source: 0001104659-17-075428 · a4.xml · derivative · entry 2 Flanders Cynthia · CIK 0001463638 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,000 Underlying: Common Stock · 3,000 shares Expires 2023-12-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On December 27, 2017, the Reporting Person exercised her stock option to purchase 3,000 shares of the Issuer's common stock at a price of $26.88 per share. F2 · balance_after: As of the date of this filing, the total number of options owned by the Reporting Person includes (a) options to acquire 7,000 shares of common stock at a price of $26.88 per share with Date Exercisable of 12/17/2014 and Expiration Date of 12/17/2023; (b) options to acquire 10,000 shares of common stock at a price of $31.82 with Date Exercisable of 12/11/2015 and Expiration Date of 12/11/2024; (c) options to acquire 10,000 shares of common stock at a price of $30.44 per share with Date Exercisable of 1/7/2017 and Expiration Date of 1/7/2026; and (d) options to acquire 10,000 shares of common stock at a price of $71.75 per share with Date Exercisable of 1/5/2018 and Expiration Date of 1/5/2027. Read SEC document |
| December 27, 2017 Filed Dec 28, 2017 21:21 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock | 3,000 | $26.88 | $80,640.00 |
DisclosureSEC source: 0001104659-17-075428 · a4.xml · nonDerivative · entry 1 Flanders Cynthia · CIK 0001463638 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On December 27, 2017, the Reporting Person exercised her stock option to purchase 3,000 shares of the Issuer's common stock at a price of $26.88 per share. Read SEC document |
| January 19, 2017 Filed Jan 20, 2017 22:29 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionStock Option to purchase Common Stock · Derivative | 10,000 | $0.00 Strike: $18.87 | $0.00 |
DisclosureSEC source: 0001104659-17-003387 · a4.xml · derivative · entry 3 Flanders Cynthia · CIK 0001463638 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 10,000 shares Expires 2022-12-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On January 19, 2017, the Reporting Person purchased 10,000 shares of the Issuer's common stock with an exercise price of $18.87 per share through an cashless exercise of her stock option received on December 18, 2012. F3 · balance_after: As of the date of this filing, the total number of options owned by the Reporting Person includes (a) options to acquire 10,000 shares of common stock at a price of $26.88 per share with Date Exercisable of 12/17/2014 and Expiration Date of 12/17/2023; (b) options to acquire 10,000 shares of common stock at a price of $31.82 with Date Exercisable of 12/11/2015 and Expiration Date of 12/11/2024; and (c) options to acquire 10,000 shares of common stock at a price of $30.44 per share with Date Exercisable of 1/7/2017 and Expiration Date of 1/7/2026. Read SEC document |
| January 19, 2017 Filed Jan 20, 2017 22:29 UTC | ARGAN INC AGX · Entity 3828 | SaleCommon Stock | 10,000 | $70.67 | $706,711.00 |
DisclosureSEC source: 0001104659-17-003387 · a4.xml · nonDerivative · entry 2 Flanders Cynthia · CIK 0001463638 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 F2 · shares: On January 19, 2017, the Reporting Person sold the 10,000 shares of the Issuer's common stock which were acquired pursuant to the exercise of stock options on the same day [see footnote 1 above] on the open market at a price of $70.67114 per share. Read SEC document |
| January 19, 2017 Filed Jan 20, 2017 22:29 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock | 10,000 | $18.87 | $188,700.00 |
DisclosureSEC source: 0001104659-17-003387 · a4.xml · nonDerivative · entry 1 Flanders Cynthia · CIK 0001463638 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On January 19, 2017, the Reporting Person purchased 10,000 shares of the Issuer's common stock with an exercise price of $18.87 per share through an cashless exercise of her stock option received on December 18, 2012. Read SEC document |
| January 05, 2017 Filed Feb 24, 2017 22:00 UTC | ARGAN INC AGX · Entity 3828 | GrantStock Option to purchase Common Stock · Derivative | 10,000 | $0.00 Strike: $71.75 | $0.00 |
DisclosureSEC source: 0001104659-17-011622 · a4.xml · derivative · entry 2 Flanders Cynthia · CIK 0001463638 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 10,000 shares Expires 2027-01-05 F1 · shares: Pursuant to a stock option agreement dated January 5, 2017, the Reporting Person received 10-year options to purchase 10,000 shares of the Issuer's common stock with an exercise price of $71.75 per share. F2 · balance_after: As of the date of this filing, the total number of options owned by the Reporting Person includes (a) options to acquire 10,000 shares of common stock at a price of $26.88 per share with Date Exercisable of 12/17/2014 and Expiration Date of 12/17/2023; (b) options to acquire 10,000 shares of common stock at a price of $31.82 with Date Exercisable of 12/11/2015 and Expiration Date of 12/11/2024; (c) options to acquire 10,000 shares of common stock at a price of $30.44 per share with Date Exercisable of 1/7/2017 and Expiration Date of 1/7/2026; and (d) options to acquire 10,000 shares of common stock at a price of $71.75 per share with Date Exercisable of 1/5/2018 and Expiration Date of 1/5/2027. Read SEC document |
| December 21, 2016 Filed Dec 22, 2016 12:56 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionStock Option to purchase Common Stock · Derivative | 5,000 | $0.00 Strike: $17.33 | $0.00 |
DisclosureSEC source: 0001104659-16-163350 · a4.xml · derivative · entry 3 Flanders Cynthia · CIK 0001463638 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 5,000 shares Expires 2021-12-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: On December 21, 2016, the Reporting Person exercised her stock option with an exercise price of $17.33 per share to purchase 5,000 shares of the Issuer's common stock [see footnote 1 above]. F4 · balance_after: As of the date of this filing, the total number of options owned by the Reporting Person includes (a) options to acquire 10,000 shares of the Issuer's common stock at a price $18.87 with Date Exercisable of 12/18/2013 and Expiration Date of 12/18/2022, (b) options to acquire 10,000 shares of common stock at a price of $26.88 per share with Date Exercisable of 12/17/2014 and Expiration Date of 12/17/2023; (c) options to acquire 10,000 shares of common stock at a price of $31.82 with Date Exercisable of 12/11/2015 and Expiration Date of 12/11/2024; and (d) options to acquire 10,000 shares of common stock at a price of $30.44 per share with Date Exercisable of 1/7/2017 and Expiration Date of 1/7/2026. Read SEC document |
| December 21, 2016 Filed Dec 22, 2016 12:56 UTC | ARGAN INC AGX · Entity 3828 | SaleCommon Stock | 5,000 | $74.43 | $372,150.00 |
DisclosureSEC source: 0001104659-16-163350 · a4.xml · nonDerivative · entry 2 Flanders Cynthia · CIK 0001463638 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 F2 · shares: On December 21, 2016, the Reporting Person sold the 5,000 shares of the Issuer's common stock which were acquired pursuant to the exercise of stock options on the same day [see footnote 1 above] on the open market at a price of $74.43 per share [see footnote 1 above]. Read SEC document |
| December 21, 2016 Filed Dec 22, 2016 12:56 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock | 5,000 | $17.33 | $86,650.00 |
DisclosureSEC source: 0001104659-16-163350 · a4.xml · nonDerivative · entry 1 Flanders Cynthia · CIK 0001463638 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On December 21, 2016, the Reporting Person purchased 5,000 shares of the Issuer's common stock with an exercise price of $17.33 per share through an cashless exercise of her stock option received on December 20, 2011. Read SEC document |
| September 26, 2016 Filed Sep 27, 2016 20:04 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionStock Option to purchase Common Stock · Derivative | 10,000 | $0.00 Strike: $14.05 | $0.00 |
DisclosureSEC source: 0001104659-16-146809 · a4.xml · derivative · entry 3 Flanders Cynthia · CIK 0001463638 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 10,000 shares Expires 2019-04-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: On September 26, 2016, the Reporting Person exercised her stock option with an exercise price of $14.05 per share to purchase 10,000 shares of the Issuer's common stock [see footnote 1 above]. F4 · balance_after: The total number of options owned by the Reporting Person includes options to acquire 45,000 shares of the Issuer's Common Stock with Exercise Prices ranging from $17.33 to $31.82 with Dates Exercisable ranging from December 20, 2012 to January 7, 2017 and Expiration Dates ranging from December 20, 2021 to January 7, 2026. Read SEC document |
| September 26, 2016 Filed Sep 27, 2016 20:04 UTC | ARGAN INC AGX · Entity 3828 | SaleCommon Stock | 10,000 | $57.24 | $572,366.00 |
DisclosureSEC source: 0001104659-16-146809 · a4.xml · nonDerivative · entry 2 Flanders Cynthia · CIK 0001463638 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 F2 · shares: On September 26, 2016, the Reporting Person sold the 10,000 shares of the Issuer's common stock which were acquired pursuant to the exercise of stock options on September 26, 2016 [see footnote 1 above] on the open market at a price of $57.2366 per share. Read SEC document |
| September 26, 2016 Filed Sep 27, 2016 20:04 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock | 10,000 | $14.05 | $140,500.00 |
DisclosureSEC source: 0001104659-16-146809 · a4.xml · nonDerivative · entry 1 Flanders Cynthia · CIK 0001463638 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On September 26, 2016, the Reporting Person purchased 10,000 shares of the Issuer's common stock with an exercise price of $14.05 per share through an cashless exercise of her stock option received pursuant to an agreement dated April 9, 2010. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.